Patent 7745636 was granted and assigned to Bristol-Myers Squibb on June, 2010 by the United States Patent and Trademark Office.
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.